Premium
Adjuvant and down‐staging treatment with imatinib in gastrointestinal stromal tumors
Author(s) -
Nilsson B.,
Andersson A.,
Ahlman H.
Publication year - 2008
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21043
Subject(s) - medicine , university hospital , nuclear medicine
Background: GISTs are gastrointestinal mesenchymal tumours that express the type III receptor tyrosine kinase KIT. The KIT proto-oncogene encodes the receptor KIT. Most GISTs have gain-of-function ...